In acquiring BRAHMS (Hennigsdorf, Germany) last October, Thermo Fisher Scientific (Waltham, MA) took over marketing of BRAHMS’s blood biomarker test for myocardial infarction, “Copeptin.”  While it typically takes six hours to diagnose or rule out a heart attack using an ECK and Troponin, Copeptin reaches that determination if a few minutes.  MORE